231 related articles for article (PubMed ID: 14662856)
1. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
Frenkel D; Huang Z; Maron R; Koldzic DN; Hancock WW; Moskowitz MA; Weiner HL
J Immunol; 2003 Dec; 171(12):6549-55. PubMed ID: 14662856
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke.
Frenkel D; Huang Z; Maron R; Koldzic DN; Moskowitz MA; Weiner HL
J Neurol Sci; 2005 Jun; 233(1-2):125-32. PubMed ID: 15894335
[TBL] [Abstract][Full Text] [Related]
3. Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.
Frenkel D; Pachori AS; Zhang L; Dembinsky-Vaknin A; Farfara D; Petrovic-Stojkovic S; Dzau VJ; Weiner HL
Int Immunol; 2009 Jul; 21(7):817-29. PubMed ID: 19515797
[TBL] [Abstract][Full Text] [Related]
4. The ICOS molecule plays a crucial role in the development of mucosal tolerance.
Miyamoto K; Kingsley CI; Zhang X; Jabs C; Izikson L; Sobel RA; Weiner HL; Kuchroo VK; Sharpe AH
J Immunol; 2005 Dec; 175(11):7341-7. PubMed ID: 16301640
[TBL] [Abstract][Full Text] [Related]
5. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.
Rynda-Apple A; Huarte E; Maddaloni M; Callis G; Skyberg JA; Pascual DW
Eur J Immunol; 2011 Feb; 41(2):313-23. PubMed ID: 21268002
[TBL] [Abstract][Full Text] [Related]
6. Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.
Schmidt CS; Zhao J; Chain J; Hepburn D; Gitter B; Sandusky G; Chintalacharuvu S; Glasebrook A; Na S
J Immunol; 2005 Aug; 175(4):2286-92. PubMed ID: 16081797
[TBL] [Abstract][Full Text] [Related]
7. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
[TBL] [Abstract][Full Text] [Related]
8. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes.
Slavin AJ; Maron R; Weiner HL
Int Immunol; 2001 Jun; 13(6):825-33. PubMed ID: 11369711
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
[TBL] [Abstract][Full Text] [Related]
10. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
11. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
[TBL] [Abstract][Full Text] [Related]
12. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
Komiyama Y; Nakae S; Matsuki T; Nambu A; Ishigame H; Kakuta S; Sudo K; Iwakura Y
J Immunol; 2006 Jul; 177(1):566-73. PubMed ID: 16785554
[TBL] [Abstract][Full Text] [Related]
13. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
14. DRĪ±1-MOG-35-55 Reduces Permanent Ischemic Brain Injury.
Wang J; Ye Q; Xu J; Benedek G; Zhang H; Yang Y; Liu H; Meza-Romero R; Vandenbark AA; Offner H; Gao Y
Transl Stroke Res; 2017 Jun; 8(3):284-293. PubMed ID: 27988839
[TBL] [Abstract][Full Text] [Related]
15. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
Furlan R; Kurne A; Bergami A; Brambilla E; Maucci R; Gasparini L; Butti E; Comi G; Ongini E; Martino G
J Neuroimmunol; 2004 May; 150(1-2):10-9. PubMed ID: 15081244
[TBL] [Abstract][Full Text] [Related]
16. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
[TBL] [Abstract][Full Text] [Related]
17. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance.
Cascio JA; Haymaker CL; Divekar RD; Zaghouani S; Khairallah MT; Wan X; Rowland LM; Dhakal M; Chen W; Zaghouani H
J Immunol; 2013 Jun; 190(12):6004-14. PubMed ID: 23686493
[TBL] [Abstract][Full Text] [Related]
19. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
Oliver AR; Lyon GM; Ruddle NH
J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
[TBL] [Abstract][Full Text] [Related]
20. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
